Atopic dermatitis Asana BioSciences

Asana starts Phase llb trial of ASN002 for atopic dermatitis

Asana BioSciences has commenced the RADIANT Phase llb trial to investigate the efficacy, safety, tolerability, and pharmacokinetics of ASN002 to…